In 2007, an individual with HIV infection and leukemia underwent hematopoietic stem cell transplant (HSCT) in Berlin, using cells from a donor who was homozygous for CCR5-delta32, a mutation that renders CD4 cells resistant to CCR5-tropic HIV. Here, CD4 is linked to HIV infectious disease.